Journal of the Chemical Society Perkin Transactions 1 · 2000 · 23 citations · 49 references
MedicineMedicinal ChemistryPharmacologyBiochemical PharmacologyBioisosterismMolecular PharmacologyLigand BindingN-linked GlycosylationAdenosine Diphosphate RibosylationAdenosine Receptor SignalingAdenosine TriphosphatasesAdenosine Triphosphate SynthesisGlycosyl Acceptor SynthesisHydrolysisInositol 1, 4, 5-Trisphosphate Receptor SignalingInositol 1, 4, 5-Trisphosphate Receptors
A convergent route is described to the super-potent 1D-myo-inositol 1,4,5-trisphosphate receptor agonist adenophostin A (2) and analogues 5 and 7, in which the glucose bisphosphate unit is replaced by corresponding xylose bisphosphate and mannose bisphosphate units respectively. Adenosine was converted into its 2′,3′-O-p-methoxybenzylidene derivative 8ab, which was selectively N6-dimethoxytritylated by a transient protection method. 5′-O-Benzylation followed by reductive acetal cleavage gave, after separation from its 3′-O-p-methoxybenzyl isomer, the versatile glycosyl acceptor 5′-O-benzyl-N6-dimethoxytrityl-2′-O-p-methoxybenzyladenosine 13. Coupling of 13 with selectively protected glucopyranosyl, xylopyranosyl or mannopyranosyl dimethyl phosphites gave the required 3′-O-α-pyranosyl adenosine derivatives. Acidic hydrolysis gave corresponding N6-unprotected triols which were phosphitylated using bis(benzyloxy)(diisopropylamino)phosphine and imidazolium triflate without further N6-protection. Deprotection gave the target trisphosphates 2, 5 and 7. Synthetic adenophostin A (2) was identical with a sample of natural material in all respects. Analogues 5 and 7 will be useful for structure–activity studies on the adenophostins.
49